Risk factors and timing of default from treatment for non-multidrug- resistant tuberculosis in Moldova

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 3, 2013, Pages 373-380

  Jenkins, H E ^a,b   Ciobanu, A ^c   Plesca, V ^c   Crudu, V ^d   Galusca, I ^c   Soltan, V ^d   Cohen, T ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Health Policy Division   (Moldova)

^d Center for Health Policies and Studies   (Moldova)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Drug resistance; Eastern Europe; Hospitalization; Prisons

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ASSESSMENT; DEMOGRAPHY; DISEASE SURVEILLANCE; DRUG EFFECT; EDUCATIONAL STATUS; FEMALE; HIGH RISK PATIENT; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLDOVA; PATIENT ATTITUDE; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOCIAL STATUS; TREATMENT OUTCOME; TREATMENT PLANNING; TREND STUDY; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; INSTITUTIONALIZATION; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; MEDICATION ADHERENCE; MOLDOVA; MULTIVARIATE ANALYSIS; PATIENT DISCHARGE; PRISONERS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84874048116     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0464     Document Type: Article

References (30)

1. World Health Organization. Global tuberculosis control 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 2011. http://www.who.int/tb/ publications/global-report/2011/gtbr11-full.pdf Accessed November 2012.
2. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/publications/2010/ 9789241599191-eng.pdf Accessed November 2012.
3. Pablos-Mendez A, Knirsch C A, Barr R G, Lerner B H, Frieden T R. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 1997; 102: 164-170.
4. Verver S, Warren R M, Beyers N, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171: 1430-1435.
5. Kolappan C S R, Karunakaran K, Narayanan P R. Mortality of tuberculosis patients in Chennai, India. Bull World Health Organ 2006; 84: 555-560.
6. Weis S E, Slocum P C, Blais F X, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.
7. Jenkins H E, Plesca V, Ciobanu A, et al. Assessing spatial heterogeneity of MDR-TB in a high-burden country. Eur Respir J 2012; Oct 25. [Epub ahead of print]
8. Hasker E, Khodjikhanov M, Usarova S, et al. Default from tuberculosis treatment in Tashkent, Uzbekistan: who are these defaulters and why do they default? BMC Infect Dis 2008; 8: 97.
9. Miller A C, Gelmanova I Y, Keshavjee S, et al. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. Int J Tuberc Lung Dis 2012; 16: 891-896.
10. Gelmanova I Y, Keshavjee S, Golubchikova V T, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 2007; 85: 703-711.
11. Jakubowiak W M, Bogorodskaya E M, Borisov E S, Danilova D I, Kourbatova E K. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis 2007; 11: 46-53.
12. Kliiman K, Altraja A. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010; 14: 454-463.
13. National Bureau of Statistics of the Republic of Moldova. 2004 Population Census results. Chisinau, Republic of Moldova: National Bureau of Statistics, 2004. http://www.statistica.md/pageview.php?l=en&idc=295 Accessed November 2012.
14. International Organization for Migration. Migration in Moldova: a country profile 2008. Geneva, Switzerland: IOM, 2008. http://publications.iom.int/ bookstore/free/Moldova-Profile2008.pdf Accessed November 2012.
15. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/ publications/2010/9789241547833-eng.pdf Accessed November 2012.
16. Ministry of Health and Social Protection; Cu privire la imple-mentarea progamului national de control si profilaxie a tuber-culozei in Republica Moldova, pentru anii 2006-2010 [TB treatment guidelines]. Order 180, Annex 11. Chisinau, Republic of Moldova: Ministry of Health and Social Protection, 2006. [Moldovan]
17. Dara M, Kluge H. Roadmap to prevent and combat drug-resistant tuberculosis. Copenhagen, Denmark: WHO Regional Office for Europe, 2011. http://www.euro.who.int/-data/assets/pdf-file/0014/152015/e95786.pdf Accessed November 2012.
18. Soltan V, Henry A K, Crudu V, Zatusevski I. Increasing tuber-culosis case detection: lessons from the Republic of Moldova. Bull World Health Organ 2008; 86: 71-76.
19. Ditah I C, Reacher M, Palmer C, et al. Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax 2008; 63: 440-446.
20. Cox D R. Regression models and life tables. J Roy Statist Soc Ser B 1972; 34: 187-220.
21. Schoenfeld D. Partial residuals for the proportional hazards regression-model. Biometrika 1982; 69: 239-241.
22. Shin S S, Pasechnikov A D, Gelmanova I Y, et al. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 2006; 10: 402-408.
23. Cummings K C, Mohle-Boetani J, Royce S E, Chin D P. Movement of tuberculosis patients and the failure to complete anti-tuberculosis treatment. Am J Respir Crit Care Med 1998; 157: 1249-1252.
24. Kruk M E, Schwalbe N R, Aguiar C A. Timing of default from tuberculosis treatment: a systematic review. Trop Med Int Health 2008; 13: 703-712.
25. Greenfield S F, Shields A, Connery H S, et al. Integrated management of physician-delivered alcohol care for tuberculosis patients: design and implementation. Alcohol Clin Exp Res 2010; 34: 317-330.
26. Shin S S, Livchits V, Nelson A K, et al. Implementing evidence-based alcohol interventions in a resource-limited setting: novel delivery strategies in Tomsk, Russia. Harv Rev Psychiatry 2012; 20: 58-67.
27. Nyirenda T E, Harries A D, Gausi F, et al. Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S21-S28.
28. Crudu V, Rüsch-Gerdes S, Niemann S, et al. Nosocomial transmission of multidrug-resistant M. tuberculosis strains in a high-incidence setting [Abstract]. In: Abstract book. 41st World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union), Berlin, Germany, 11-15 November 2010.
29. Int J Tuberc Lung Dis 2010; 14 (Suppl 2): S353-S354. http://www.theunion. org/images/stories/journal/ABSTRACT-BOOK-2010-Web.pdf Accessed January 2013.
30. Nodieva A, Jansone I, Broka L, Pole I, Skenders G, Baumanis V. Recent nosocomial transmission and genotypes of multi-drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2010; 14: 427-433.